Daniel Loeb’s Best Performing Stocks in 2011

Third Point’s Daniel Loeb is one of the most successful hedge fund managers of 2010. Third Point’s flagship fund returned 41.7% in 2010. NXP Semiconductors (NXPI) returned 54% between September 30th and December 9th, when Dan Loeb penned his third quarter investor letter. Daniel Loeb was extremely bullish about NXP Semiconductors in his letter. This is what he said:

THIRD POINT

“In August, we participated in the IPO of NXP Semiconductors NV, a leading semiconductor manufacturer emerging from a 2006 LBO led by KKR, Silver Lake, Bain and Apax. We had successfully participated in the NXP story via its distressed debt in late 2009, and were prepared for the IPO, which came at a very attractive valuation of roughly 5.5x estimated 2011 EPS. The company is in the final stages of completing a substantial operational and capital structure restructuring, which is driving strong free cash flow, rapid deleveraging and attractive new opportunities like a leadership position (>50% market share) in Near Field Communications, a fast emerging mobile payment technology being adopted by Google Android, Nokia and Blackberry. Despite a strong recent run in the shares, limited familiarity and misconceptions leave it trading at a 50% discount to peer P/E and FCF multiples and lagging the performance of other comparably levered, post‐LBO  IPOs such as Sensata and Avago. As NXP’s growth, profitability and cash flow attributes (it will generate close to $3 in 2011 FCF) become better understood, we see substantial upside in the name.”

Since December 9th, NXP returned an additional 42%, whereas Sensata (ST) returned 10% and Avago (AVGO) returned 12%. Outsiders monkeying Dan Loeb’s strong endorsement would have beaten the benchmark securities and the market by more than 30 percentage points. One shouldn’t think that Dan Loeb is doing a public service by endorsing these stocks. At the end of November, NXPI’s market price was $12.58 with an average daily transaction volume of 220,000 shares during the previous 20 trading days. The stock price climbed to $18.44 by December 8th  , with an average trading volume of 728,000 shares during the first six trading days of December. You don’t need to be a genius to predict who was buying those shares days before Dan Loeb’s letter to his investors.

Dan Loeb’s Offshore Fund returned an additional 3.9% in January beating both the SPY and fellow hedgies David Einhorn and Whitney Tilson. Dan Loeb’s other big winners in January were Potash (POT), Smurfit Stone Container (SSCC), Massey Energy (MEE) and Aveta. His biggest losers were GLD, Brenntag AG, Mead Johnson Nutrition (MJN), African Barrick Gold, and Accuride Corp.

Potash (POT) returned 17.7% in January. This is one of hedge funds’ favorite investmentsMohnish Pabrai also has Potash in his portfolio. In January, Smurfit-Stone Container Store announced that it will be acquired by Rock Tenn Co (RKT) for $35 a share. The stock gained 46% in January. David Tepper and Barry Rosenstein were other SSCC investors.   In January Alpha Natural Resources (ANR) also agreed to buy Massey Energy for a 21% premium. MEE returned 17% in January, contributing to Loeb’s outstanding performance.  Some of Alpha Natural Resources insiders were selling weeks before the announcement.

Gold is the largest position in Loeb’s portfolio. GLD lost 6.4% in January. There are several hedge funds that invested in gold and suffered from the decline in gold. The decline in African Barrick Gold, which trades in London, reached almost 18% in January. Mead Johnson Nutrition’s (MJN) decline reached 7% in January, underperforming the SPY’s 2.4% increase. Finally Accuride (ACW) lost nearly 6% in January.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!